By Lecia Bushak | Thu, 10/24/2013 - 20:04
The consequences of a fungal outbreak that peaked last fall still linger for those who took a tainted steroid injection.
By Martin Grens | Tue, 01/08/2013 - 12:26
The person hired to run the bankrupt pharmacy linked to a deadly U.S. meningitis outbreak is "hopelessly conflicted" and should be removed from the job, a U.S. Justice Department official said.
By Martin Grens | Mon, 11/19/2012 - 16:56
Republicans on a congressional panel investigating a deadly meningitis outbreak told FDA not to expect new authority to prevent future problems until the agency hands over documents about its role in the current crisis.
By Martin Grens | Fri, 11/09/2012 - 11:30
Ameridose LLC, an affiliate of NECC at the heart of the deadly U.S. meningitis outbreak, is laying off about 90 percent of its workforce.
By Makini Brice | Thu, 11/08/2012 - 11:22
The director of NECC was fired because he had ignored a complaint lodged against the company in July.
By Amber Moore | Fri, 11/02/2012 - 10:11
Bacteria were found in the recent recalled products of the New England Compounding Center that has been associated with the recent meningitis outbreak.
By Makini Brice | Mon, 10/29/2012 - 12:15
Staffers at the New England Compounding Center knew of contamination in the pharmacy for months, but chose to do nothing.
By Martin Grens | Sat, 10/27/2012 - 11:48
The FDA said it found "greenish black foreign matter" and other contaminants in an injectable steroid produced by the New England Compounding Center.
By Martin Grens | Sat, 10/27/2012 - 11:31
Interviews with former NECC employees and a review of internal documents and state records show how regulators failed to punish the company despite repeated violations of the rules.
By Martin Grens | Wed, 10/24/2012 - 11:39
Victims of a deadly U.S. meningitis outbreak are starting to sue the physicians and clinics that administered tainted steroid shots, and the success of the suits could hinge on whether judges decide the injections are subject to product liability or medical malpractice laws.
By Martin Grens | Tue, 10/23/2012 - 10:54
The pharmacy tied to a deadly U.S. meningitis outbreak escaped harsh punishment from health regulators several times that has raised questions about oversight of the customized drug mixing industry.
By Martin Grens | Tue, 10/23/2012 - 09:05
U.S. and Massachusetts state health regulators were aware in 2002 that steroid treatments from the pharmacy at the center of a deadly meningitis outbreak could cause adverse patient reactions.
By Martin Grens | Sat, 10/20/2012 - 10:06
The list of NECC products fills 70 pages. The FDA specifically advised doctors to alert patients who received injected NECC drugs during heart and eye surgeries that the company produced after May 21.